Mattern Capital Management LLC Acquires 2,642 Shares of Colgate-Palmolive (NYSE:CL)

Mattern Capital Management LLC increased its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 2.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 94,805 shares of the company’s stock after acquiring an additional 2,642 shares during the quarter. Mattern Capital Management LLC’s holdings in Colgate-Palmolive were worth $8,619,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of CL. Union Bancaire Privee UBP SA bought a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $32,000. Hager Investment Management Services LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $36,000. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $42,000. Roxbury Financial LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter valued at approximately $43,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $53,000. 80.41% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

CL has been the topic of several research reports. TD Cowen decreased their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. Barclays cut their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Finally, UBS Group cut their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $101.16.

Read Our Latest Stock Analysis on CL

Colgate-Palmolive Stock Performance

NYSE:CL opened at $87.80 on Friday. The company has a fifty day moving average of $89.02 and a 200-day moving average of $95.99. The firm has a market capitalization of $71.25 billion, a P/E ratio of 24.94, a P/E/G ratio of 4.12 and a beta of 0.44. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a twelve month low of $84.45 and a twelve month high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the company posted $0.87 earnings per share. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.76 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were paid a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.